Professional service provider of Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO)
The manufacturing base is equipped with more than 30 reaction kettles with the capacity of 50L and 20 reaction kettles with the capacity of 200L in Howei.
Pilotscale experiment and mass production
Every life should be protected doubly.
As a professional service provider of Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO), Howei Pharm was set up in Guangzhou, China, in 2011 by overseas returnee and other related capitals, and won the First-Round Business Angel in the following year. The company mainly engages in providing customized production and research & development outsourcing services to biological pharmaceutical and life sciences related enterprises and institutions.
The research team of Howei is made up of the world's top scientists, most of whom have work experience in top international scientific research institutions. The team is very successful in many fields, such as micromolecule building blocks, polypeptide, polysaccharide, RNA and other fields. So far, Howei has R & D laboratories in Guangzhou, Hangzhou, Suzhou and Quebec to meet the growing R & D requirements of the company.
The production bases of Howei are located in the Optics Valley Development Zone in Wuhan, Hubei and the Special Economic Zone in Shantou, Guangdong, and they are equipped with more than 30 reaction kettles with the capacity of 50L and 20 reaction kettles with the capacity of 200L. These reaction kettles can quickly meet the customer's demand for pilotscale experiment and mass production of kg-to-tonnage.
In addition, Howei has an office in Houston, USA, so customers in North America can access to local services nearby. More...
News & Event
Howei Pharm was invited to attend the 2019 Chemical Industry Internet Development Forum
On January 11, 2019, the 2019 Chemical Industry Internet Development Forum was successfully concluded in Shanghai. Nearly 300 people from many top 500 chemical company executives, leaders of domestic chemical industry leading enterprises, industry associations, research institutions, senior chemical industry practitioners, and industry media attended the forum. Howei Pharm was invited as a special guest to attend the forum and participated in the round table.
April 18-20, 2018
Howei Pharm will be present in the CPhI Japan which will take place in Tokyo. CPhI Japan is Japan’s most comprehensive pharma event, which brings together more than 20,000 pharma industry professionals from 55+ countries. A wide range of exhibitors from all pharma areas active in Japan as well as hosting exhibitors from ingredients, contract services and biopharma through to technology, packaging and machinery.
The clean workshop in Wuhan was put into use.
August 1st, 2017
Recently, the clean workshop in Wuhan successfully passed the appraisal and formally was put into use, and the new workshop adopted independent decontamination air condition unit and centralized new exhaust blower unit. With the use of the new clean workshop, the risk of pollution is further reduced in the process of the products manufacturing and packaging.